Related Articles
Outcome of third‑line sunitinib after sequential therapy with cytokines and sorafenib in metastatic renal cell carcinoma
Prognostic effect of serum C-reactive protein kinetics on advanced renal cell carcinoma treated with sunitinib
Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience
Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma
Splice variants of lysosome‑associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells